Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2021 Apr 26;44(6):e115–e117. doi: 10.2337/dc20-3003

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the American Diabetes Association

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

PMC Copyright notice

A: Characteristics of patients enrolled in this study (n = 257; 179 men, 78 women). B: The mass peaks of each posttranslational form of serum albumin in patients with type 2 diabetes. C and D: Receiver operating characteristics curve analysis of each posttranslational modified albumin, HbA_1c, and UACR for predicting each nephropathy stage progression in patients with type 2 diabetes with G1 to G2 stage (C) and G2 to G3a stage (D). E: Kaplan-Meier curve analysis for occurrence of nephropathy stage progression (G2 to G3a) in patients with type 2 diabetes with G2 stage of nephropathy who were above or below the cutoff value of Cys-Albumin (log-rank test: P = 0.001).